Prof. Michael Verneris

Professor, with Tenure, University of Colorado Denver School of Medicine, Department of Pediatrics, Hematology/Oncology & Bone Marrow Transplant

Prof. Michael Verneris  specialized in Hematology/Oncology
Country

United States

Speciality
Hematology/Oncology
Subspeciality
Bone Marrow Disorders
Experience
33 years
Languages
English

About the expert

Dr. Michael Verneris, MD, is a distinguished professor of Pediatrics specializing in hematology, oncology, and bone marrow transplantation. With over 25 years of experience, he has held esteemed positions at institutions such as Stanford University, the University of Minnesota, and the University of Colorado. Dr. Verneris’s clinical expertise focuses on pediatric leukemia, immunotherapy, hematopoietic cell transplantation, and cellular therapies, including CAR-T and NK-cell therapies. He has contributed to groundbreaking research on immune system modulation and cancer therapy. As Director of Bone Marrow Transplant and Stem Cell Therapy at Children’s Hospital Colorado, Dr. Verneris provides cutting-edge care for complex hematologic conditions.

Videos of the expert

    Prof. Michael Verneris, MD, is a highly accomplished pediatric hematologist, oncologist, and stem cell transplant specialist with over 25 years of clinical and research expertise. A graduate of Brown University’s Warren Alpert School of Medicine, Dr. Verneris completed his pediatric residency at Children’s National Medical Center, followed by a fellowship in hematology/oncology and bone marrow transplantation at Stanford University. His career is marked by leadership roles at top institutions, including the University of Minnesota and the University of Colorado, where he currently serves as Director of Bone Marrow Transplant and Stem Cell Therapy at Children’s Hospital Colorado.

    Prof. Verneris is renowned for his expertise in treating pediatric leukemia and other hematologic malignancies, focusing on advanced cellular therapies such as CAR-T, NK-cell therapy, and stem cell transplantation. His clinical work addresses complex cases involving relapse, refractory disease, and graft-versus-host disease, utilizing innovative approaches to enhance patient outcomes. A strong proponent of evidence-based medicine, he has also contributed significantly to the development of immunotherapeutic strategies targeting cancer at its cellular level.

    In addition to his clinical achievements, Dr. Verneris is an accomplished researcher and educator. He has authored numerous peer-reviewed publications and book chapters, focusing on topics such as immune reconstitution, natural killer cells, and transplant immunology. He has been a principal investigator on several high-impact clinical trials and NIH-funded studies, advancing the fields of cellular therapy and transplantation. His work has garnered prestigious accolades, including the Laura Barton Endowed Chair in Pediatric Bone Marrow Transplant and recognition in “Best Doctors in America.”

    Dr. Verneris actively engages in mentorship, shaping the next generation of leaders in pediatric oncology and transplantation. He has served on multiple advisory boards and committees, including the American Society of Hematology and the American Society for Transplantation and Cellular Therapy. Through his leadership, research, and clinical care, Dr. Verneris continues to transform the landscape of pediatric cancer treatment, offering hope to families facing life-threatening conditions.

  • Translational Sciences Lead

    2023 - Today

    Gates Institute University of Colorado Anschutz Medical Campus, Cancer Center

  • Medical and Scientific Director of the Cellular Therapy Program (CTOP)

    2020 - 2023

    University of Colorado Anschutz Medical Campus, Cancer Center

  • Co-Leader, Tumor Host Immunity Program

    2018 - Today

    University of Colorado Anschutz Medical Campus, Cancer Center

  • Director, Bone Marrow Transplant and Stem Cell Therapy

    2016 - Today

    University of Colorado School of Medicine Children’s Hospital Colorado

  • Professor, with Tenure

    2016 - Today

    University of Colorado Denver School of Medicine, Department of Pediatrics, Hematology/Oncology & Bone Marrow Transplant

  • Vice Chair for Research

    2015 - 2016

    University of Minnesota, Department of Pediatrics

  • Professor

    2015 - 2016

    University of Minnesota, Medical School, Twin Cities Campus Department of Pediatrics, Division of Blood and Marrow Transplantation

  • Consultant

    2009 - 2016

    National Marrow Donor Program (NMDP) Institutional Reviewer Board (IRB)

  • Consultant

    2006 - Today

    OptumHealth Care Solutions Clinical Sciences Institute, Bone Marrow Transplant Expert Panel

  • Staff Physician

    2002 - 2016

    University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota

  • Staff Physician

    1998 - 2000

    University of California at San Francisco, Department of Pediatrics Division of Bone Marrow Transplantation, San Francisco, California

  • American Board of Pediatrics Hematology/Oncology

    1998

  • American Board of Pediatrics

    1995

  • Chair, CIBMTR (Center for International Blood & Marrow Transplant Research) Advisory Committee (2020)

  • Cellular Therapy Committee (2016)

  • Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Pediatric Transplantation & Cellular Therapy (2007)

  • American Society for Blood and Marrow Transplantation (2006)

  • American Society of Hematology (1997)

Other experts inthe same speciality

Doctor Gillian Clare Lowe  specialized in Hematology/Oncology

Doctor Gillian Clare Lowe

Consultant Haematologist, University Hospital Birmingham and Honorary Senior Clinical Lecturer, Institute of Cardiovascular Sciences, University of Birmingham, UK.

More about the expert
Prof. Ajay Vora   specialized in Hematology/Oncology

Prof. Ajay Vora

Honorary Professor of Paediatric Haematology at University of Sheffield and Consultant Paediatric Haematologist at Great Ormond Street Hospital, UK.

More about the expert
Prof. Andrés José María Ferreri  specialized in Hematology/Oncology

Prof. Andrés José María Ferreri

Consultant Hematologist and Clinical Oncologist in IRCCS San Raffaele Scientific Institute

More about the expert
Prof. Ciro Rinaldi   specialized in Hematology/Oncology

Prof. Ciro Rinaldi

Professor of Haematology and Biomedical Science, University of Lincoln

More about the expert
Dr. Karen Breen  specialized in Hematology/Oncology

Dr. Karen Breen

Consultant Hematologist at Guys and St Thomas’ NHS Foundation Trust, UK.

More about the expert
Prof. Prakash Satwani  specialized in Hematology/Oncology

Prof. Prakash Satwani

Professor of Pediatrics at Columbia University Irving Medical Center New York

More about the expert
Dr. Jesus Alcaraz Rubio  specialized in Hematology/Oncology

Dr. Jesus Alcaraz Rubio

Head of the Hematology Units at the Murcian Union of Hospitals, Spain

More about the expert
Dr. Irmel A. Ayala  specialized in Hematology/Oncology

Dr. Irmel A. Ayala

Pediatric Hematologist–Oncologist; Director, Hemophilia & Bleeding Disorders Treatment Center, Johns Hopkins All Children’s Hospital; Assistant Professor, Department of Pediatrics, University of South Florida.

More about the expert
Docspert news

Our network includes more than 1000 international experts in more than 1200 specialities and sub-specialities

See experts in all specialities
team map
Contact us
Docspert Health
Online